Responses
Immune cell therapies and immune cell engineering
Original research
Antibody-induced erythrophagocyte reprogramming of Kupffer cells prevents anti-CD40 cancer immunotherapy-associated liver toxicity
Compose a Response to This Article
Other responses
No responses have been published for this article.
